Home
About
FAQ
History (18)
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patients.
Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis.
Risky Behavior: Hospital Transfers Associated with Early Mortality and Rates of Goals of Care Discussions.
"Now We Are Seeing the Tides Wash In": Trauma and the Opioid Epidemic in Rural Appalachian Ohio.
Social support modifies the association between hazardous drinking and depression symptoms among ART clients in Vietnam.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (17)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Kathleen L. Egan PhD, MS
Wake Forest School of Medicine
Why?
Nicklaus P. Ashburn MD, MS
Wake Forest School of Medicine
Why?
Jason P. Stopyra MD, MS
Wake Forest School of Medicine
Why?
Candice J. McNeil MD, MPH, FACP, FAAP
Wake Forest School of Medicine
Why?
James C. Eisenach MD
Wake Forest School of Medicine
Why?
Erin W. Barnes MD
Wake Forest School of Medicine
Why?
Anna C. Snavely PhD
Wake Forest School of Medicine
Why?
Carlyle P. Hamsher MD
Wake Forest School of Medicine
Why?
Chuanyao Tong MD
Wake Forest School of Medicine
Why?
Joshua F. Nitsche MD, PhD
Wake Forest School of Medicine
Why?
Mei-Chuan Ko PhD
Wake Forest School of Medicine
Why?
Kathryn E. Lancaster PhD, MPH
Wake Forest School of Medicine
Why?
Medge D. Owen MD
Wake Forest School of Medicine
Why?
Rebecca E. Wells MD, MPH
Wake Forest School of Medicine
Why?
Edgar A. Romero-Sandoval MD, PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 2
Next
Prev
Search Criteria
Naloxone
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions